HAMLET Protein announced that it is doubling the capacity of its U.S. production plant in Findlay, Ohio, to meet global demand for high-quality soy proteins for specialty feed.
By next fall, the plant's second processing line is scheduled to go into operation to serve customers in North America and worldwide, Hamlet said.
The investment is a response to rapidly developing sales of the company's nutritional soy protein ingredients, which are currently produced in Horsens, Denmark, and Findlay.
Over the past four years, Hamlet said it has experienced a significant increase in demand for quality proteins that optimize nutritional uptake from feed and support healthy young animal growth.
"The rise in global food demand has created an urgent need for more efficient animal production. This, in turn, has pushed up demand for consistent supplies of quality protein, a trend that has drawn more attention to our strong value proposition. As a result, we are experiencing substantial sales growth across our product range," Hamlet chief commercial officer Soren Bank said. "Once our extra processing line is in place, we will not only offer higher volumes but also improved flexibility of supply for customers globally."
The Findlay plant began production in early 2012. Since then, sales growth has extended far beyond North America to South America and Asia.
"We target emerging markets where industrial meat production brings greater demands for quality and efficiency," Bank added.
The new processing line will be installed in the existing facility.